Study ID: GA/9016 (FORTE)
Study Title
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
Teva Identifier
- GA/9016 (FORTE)
ClinicalTrials.gov Identifier
- NCT00337779
Study Status
- Completed
Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate (GA) 40 mg | Drug: glatiramer acetate 20 mg
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 08/01/2006 - 10/01/2008
Phase
- Phase 3
Study Type
Interventional
